Key result
Low-dose hyperbaric bupivacaine (6.5 mg) combined with sufentanil for cesarean delivery reduces hypotension but results in slower onset and shorter duration of anesthesia.
This editorial questions the practical benefits of low-dose spinal anesthesia for cesarean delivery, highlighting trade-offs like shorter duration and slower onset.
To the Editor: Van de Velde et al. (1) convincingly demonstrate that just 6.5 mg of hyperbaric bupivicaine combined with 2.5 μg of sufentanil can provide anesthesia for cesarean delivery while reducing the incidence of hypotension associated with higher doses. However, such doses are associated with significantly decreased duration, as their study demonstrates. Patients in their LOW-group had slower onset of T3 block, shorter duration of anesthesia, and increased requirements for analgesia after delivery. An epidural catheter was required to successfully complete the surgical anesthesia. What exactly has been gained by this approach and what is the associated cost? Are we better off using a technique that requires longer to place, longer for onset of anesthesia, and an indwelling epidural catheter to complete the operation and provide postoperative analgesia? Is this better than simply using a higher dose of local anesthetic, and treating hypotension with judiciously titrated vasopressors (2–4)? Philip J. Balestrieri, MA, MD Department of Anesthesiology University of Virginia Health Systems Charlottesville, Virginia [email protected]
No takes yet. Share an insight, caveat, or question.
Philip J. Balestrieri (2007) conducted a letter in Cesarean delivery. Low-dose hyperbaric bupivacaine and sufentanil vs. Higher doses of local anesthetic was evaluated. Low-dose hyperbaric bupivacaine (6.5 mg) combined with sufentanil for cesarean delivery reduces hypotension but results in slower onset and shorter duration of anesthesia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: